SYS-CON MEDIA Authors: Jayaram Krishnaswamy, Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley

News Feed Item

GENTIUM S.P.A. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Gentium S.p.A. and Its Board -- GENT

NEW YORK, NY -- (Marketwired) -- 01/21/14 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of holders of Gentium S.p.A. ("Gentium" or the "Company") (NASDAQ: GENT) American Depositary Shares ("ADSs") as of December 19, 2013.

For more information, click here: http://zlk.9nl.com/gentium-spa-gent.

The complaint is filed against Gentium, members of its Board, Jazz Pharmaceuticals Public Limited Company ("Jazz"), and a Jazz subsidiary, in relation to the proposed acquisition of Gentium by Jazz. The complaint alleges that, in an attempt to secure shareholder support for Jazz's acquisition of the Company, Gentium filed a materially false and misleading Schedule 14D9 with the Securities and Exchange Commission.

To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/gentium-spa-gent.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.